BBCA Group 丰原集团
BBCA Group is a large-scale biological fermentation technology company and a national innovation enterprise in China. One of the largest biochemical producers in Asia with manufacturing facilities, offices and laboratories within China and abroad. Counting with more than 8,000 employees around the globe, our company is currently broadening its business footprint in Asia, Europe and South America. …
Profile
BBCA Group (Anhui Fengyuan Group) is a Chinese mixed-ownership conglomerate founded in 1958 and headquartered in Bengbu, Anhui. It specializes in biological fermentation, producing organic acids, amino acids, vitamins, and polylactic acid (PLA) for food, feed, and pharmaceutical applications. The company operates as a private entity with management control and municipal government participation.
BBCA maintains a full-chain PLA production model and utilizes proprietary fermentation technologies, including “bio-chip” technology for converting crop straw into sugars. It operates manufacturing bases in China, Thailand, Hungary, and Brazil. As of 2026, the company remains active, focusing on expanding bio-based material production and sustainable agricultural processing.
Sources#
- 丰原集团
- BBCA Profile_丰原集团
- BBCA Group 2026 Company Profile: Valuation, Funding & Investors | PitchBook
- BBCA Group Company Profile - Office Locations, Competitors, Revenue, Financials, Employees, Key People, Subsidiaries | Craft.co
- WHO WE ARE - 丰原生物官网-英文
- INNOVATION - 丰原生物官网-英文
- 集团研发_丰原集团
- Overseas Industrial Companies _丰原集团
- Industry
- Biorefining, Energy, Feed, Fertilisers & plant nutrition, Food ingredients, Industrial chemistry, Packaging & plastics, Waste & circular economy
- Topics
- Organic acids & bio-based chemicals, PLA (polylactic acid), Amino acids & MSG fermentation, Vitamins, carotenoids & nutraceutical actives
- Role
- Research / RTO — “…( ) - National Engineering Research Center for Fermentation Technology ( ) - National Pharmaceutical R&D Enter…”
Bio-solutions it supplies 3
What they offer
Products: 丰原生物; 丰原药业; 泰格生物; 丰原化工装备; 丰原食品; 丰原农业; 丰原生物新材料; 丰原生物纤维; 丰原国际贸易; 丰原国货
- Applications
- Biochemical products for food additives · Biochemical products for feed additives
- Customers & partners
- 丰原药业 · 云鼎科技
- Production sites
- Thailand — Biochemical products · Hungary — Biochemical products · Brazil — Biochemical products · 泰国 — 生物化学品 · 匈牙利 — 生物化学品 · 巴西 — 生物化学品
- Products (website)
- 丰原生物 · 丰原药业 · 泰格生物 · 丰原化工装备 · 丰原食品 · 丰原农业 · 丰原生物新材料 · 丰原生物纤维 · 丰原国际贸易 · 丰原国货 · 丰原巴西工业 · 丰原索尔诺克生化
- R&D facilities
- 国家级医药研发企业技术中心 · 发酵技术国家工程研究中心 · 生物基可降解材料技术创新中心 · National Engineering Research Center for Fermentation Technology · National Pharmaceutical R&D Enterprise Technology Center
Read from the company's own website: products · production · rnd
Subsidiaries: BBCA Pharmaceutical (丰原药业) · BBCA Biochemical (丰原生物) · Tiger Biotech (泰格生物) · BBCA Biochemical Equipment (丰原化工装备) · BBCA Food (丰原食品) · BBCA Argentina Investment & Trade (丰原阿根廷投资贸易有限公司) · BBCA Brazil Industrial & Investment (丰原巴西工业投资有限公司)
News & status 6
- 2026-08-18 中国证券报
-
安徽丰原药业股份有限公司<BR/>关于公司控股股东及相关方签署股份转让协议暨控制权拟发生变更的提示性公告BBCA Group and Fengyuan Group related info: The announcement states that Bengbu Investment Group, affiliated with Fengyuan Group’s controlling interests, will become the new controlling shareholder of Xinyi Pharmaceutical (Anhui Fengyuan Pharmaceuticals) after …
- 2026-08-18 百亿债务下蚌埠首富李荣杰脱手丰原药业_新浪财经_新浪网BBCA Group 丰原集团正在通过出售丰原药业控股来缓解严重的债务与流动性压力，交易完成后实际控制权将转移至蚌埠市国资委，李荣杰将失去对丰原药业的控制。公司目前负债高企、质押股权比例极高，2025年以来业绩下滑、资金占用与治理漏洞暴露，未来需通过资产处置与改革来改善财务状况。
- 2026-08-17 丰原药业：控股股东相关方拟转让21.53%股份，控制权拟变更BBCA Group 丰原集团 is planning to transfer 21.53% of its stake in 丰原药业 through related parties to 蚌埠投资集团, changing the company’s control from 丰原集团 to 蚌埠投资集团 and shifting actual control to 蚌埠市国资委.
- 2026-08-17 丰原药业控制权将变更，蚌埠国资溢价入主BBCA Group 丰原集团当前仍为丰原药业控股股东，李荣杰曾掌控“丰原系”并控制多家上市公司，但此次控股权变更将把实际控制权转移至蚌埠市国资委旗下的蚌埠投资集团，丰原集团将成为次要股东。
- 2026-05-23 Após ‘darem balão’ em MS, chineses brigam na Justiça para reaver R$BBCA Group (丰原集团) is portrayed as an Asian company that promised a multibillion-dollar investment in Mato Grosso do Sul, Brazil, but abandoned the project, leading to disputes over tax refunds of about R$1.4 million and the return of a R$10 million donated …
- 2026-08-17 丰原药业(000153.SZ)实际控制人拟变更为蚌埠市国资委_新浪财经_新浪网BBCA Group 丰原集团 is facing a change in control: its stake in Fuyang Pharmaceutical (000153.SZ) is set to transfer to Bengbu Investment Group, making Bengbu Investment the new controlling shareholder and Bengbu City State-owned Assets Supervision and …
Network: owners, partners, peers
Ownership & investors 7
| subsidiary | BBCA Pharmaceutical |
| subsidiary | BBCA Biochemical |
| subsidiary | Tiger Biotech |
| subsidiary | BBCA Biochemical Equipment |
| subsidiary | BBCA Food |
| subsidiary | BBCA Argentina Investment & Trade |
| subsidiary | BBCA Brazil Industrial & Investment |
Similar companies
GoodBioPak · TotalEnergies Corbion · TH water soluble film and PLA film · SuplaTM, new generation bioplastics · Orinko Advanced Plastics Co., Ltd · Plastiweber · Anhui Huaheng Biotechnology Co., Ltd · ENVICCO
Identity & contacts
Contacts, people and legal identity are available to members.
Sign in as a member